HutchMED (China) LIMITED (HMDCF) Gross margin 2016–2025
HutchMED (China) LIMITED (HMDCF) gross margin by fiscal year — reported gross profit divided by reported revenue.
38.7%FY2025 · since FY2016: 31.0% → 38.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 38.7% | -6.0 pp |
| FY2024 | 44.6% | -9.5 pp |
| FY2023 | 54.1% | +27.1 pp |
| FY2022 | 27.0% | — |
| FY2017 | 29.6% | -1.4 pp |
| FY2016 | 31.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →